Longbrake EE[au] - Search Results

Year	Number of Results
2007	1
2008	3
2009	1
2011	1
2013	2
2014	1
2015	3
2016	7
2017	2
2018	4
2019	2
2020	6
2021	11
2022	1

1

Sex effects across the lifespan in women with multiple sclerosis.

Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R, Cavalla P, Clerico M, Corona T, Doshi A, Fragoso Y, Jacobs D, Jokubaitis V, Landi D, Llamosa G, Longbrake EE, Maillart E, Marta M, Midaglia L, Shah S, Tintore M, van der Walt A, Voskuhl R, Wang Y, Zabad RK, Zeydan B, Houtchens M, Hellwig K. Krysko KM, et al. Among authors: longbrake ee. Ther Adv Neurol Disord. 2020 Jul 1;13:1756286420936166. doi: 10.1177/1756286420936166. eCollection 2020. Ther Adv Neurol Disord. 2020. PMID: 32655689 Free PMC article. Review.

2

Siponimod Chips Away at Progressive MS.

Longbrake EE, Hafler DA. Longbrake EE, et al. Cell. 2019 Dec 12;179(7):1440. doi: 10.1016/j.cell.2019.11.034. Epub 2019 Dec 12. Cell. 2019. PMID: 31951523 Free PMC article.

3

Influence of immunomodulatory drugs on the gut microbiota.

Cohen I, Ruff WE, Longbrake EE. Cohen I, et al. Among authors: longbrake ee. Transl Res. 2021 Jul;233:144-161. doi: 10.1016/j.trsl.2021.01.009. Epub 2021 Jan 27. Transl Res. 2021. PMID: 33515779 Review.

4

Monoclonal antibodies as disease modifying therapy in multiple sclerosis.

Longbrake EE, Parks BJ, Cross AH. Longbrake EE, et al. Curr Neurol Neurosci Rep. 2013 Nov;13(11):390. doi: 10.1007/s11910-013-0390-z. Curr Neurol Neurosci Rep. 2013. PMID: 24027005 Free PMC article. Review.

5

Effect of Multiple Sclerosis Disease-Modifying Therapies on B Cells and Humoral Immunity.

Longbrake EE, Cross AH. Longbrake EE, et al. JAMA Neurol. 2016 Feb;73(2):219-25. doi: 10.1001/jamaneurol.2015.3977. JAMA Neurol. 2016. PMID: 26720195 Review.

6

MOG-associated encephalitis following SARS-COV-2 infection.

Peters J, Alhasan S, Vogels CBF, Grubaugh ND, Farhadian S, Longbrake EE. Peters J, et al. Among authors: longbrake ee. Mult Scler Relat Disord. 2021 May;50:102857. doi: 10.1016/j.msard.2021.102857. Epub 2021 Feb 23. Mult Scler Relat Disord. 2021. PMID: 33647592 Free PMC article.

7

Can the immune system be harnessed to repair the CNS?

Popovich PG, Longbrake EE. Popovich PG, et al. Among authors: longbrake ee. Nat Rev Neurosci. 2008 Jun;9(6):481-93. doi: 10.1038/nrn2398. Nat Rev Neurosci. 2008. PMID: 18490917 Review.

8

Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?

Longbrake EE, Racke MK. Longbrake EE, et al. Expert Rev Neurother. 2009 Mar;9(3):319-21. doi: 10.1586/14737175.9.3.319. Expert Rev Neurother. 2009. PMID: 19271940 Review.

9

The Role of Immune Checkpoint Therapy in Propagating Neurologic Immune-Related Adverse Events: Inducing or "Unmasking" Autoimmunity?

Gardin T, Longbrake EE. Gardin T, et al. Among authors: longbrake ee. Neurology. 2021 Apr 20;96(16):733-734. doi: 10.1212/WNL.0000000000011812. Epub 2021 Mar 16. Neurology. 2021. PMID: 33727404 No abstract available.

10

Linking Genotype to Clinical Phenotype in Multiple Sclerosis: In Search of the Holy Grail.

Longbrake EE, Hafler DA. Longbrake EE, et al. JAMA Neurol. 2016 Jul 1;73(7):777-8. doi: 10.1001/jamaneurol.2016.1227. JAMA Neurol. 2016. PMID: 27244583 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results